Jb. Mitchell et al., REDOX GENERATION OF NITRIC-OXIDE TO RADIOSENSITIZE HYPOXIC CELLS, International journal of radiation oncology, biology, physics, 42(4), 1998, pp. 795-798
Citations number
16
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: Previous studies have shown that nitric oxide (NO) delivered
from NO donor agents sensitizes hypoxic cells to ionizing radiation. I
n the present study, nitroxyl (NO-), a potential precursor to endogeno
us NO production, was evaluated for hypoxic cell radiosensitization, e
ither alone or in combination with electron acceptor agents. Methods a
nd Materials: Radiation survival curves of Chinese hamster V79 lung fi
broblasts under aerobic and hypoxic conditions were assessed by clonog
enic assay. Hypoxia induction was achieved by metabolism-mediated oxyg
en depletion in dense cell suspensions, Cells were treated with NO- pr
oduced from the nitroxyl donor Angeli's salt (AS, Na2N2O3, sodium trio
xodinitrate), in the absence or presence of electron acceptor agents,
ferricyanide, or tempol, NO concentrations resulting from the combinat
ion of AS and ferricyanide or tempol were measured under hypoxic condi
tions using an NO-sensitive electrode. Results: Treatment of V79 cells
under hypoxic conditions with AS alone did not result in radiosensiti
zation; however, the combination of AS with ferricyanide or tempol res
ulted in significant hypoxic radiosensitization with SERs of 2.5 and 2
.1, respectively. Neither AS alone nor AS incombination with ferricyan
ide or tempol influenced aerobic radiosensitivity, The presence of NO
generated under hypoxic conditions from the combination of AS with fer
ricyanide or tempol was confirmed using an NO-sensitive electrode. Con
clusion: Combining NO- generated from AS with electron accepters resul
ts in NO generation and substantial hypoxic cell radiosensitization. N
O- derived from donor agents or endogenously produced in tumors, combi
ned with electron accepters, may provide an important strategy for rad
iosensitizing hypoxic cells and warrants in vivo evaluation. (C) 1998
Elsevier Science Inc.